研究実績

Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG0604)

Y. Kimura, S. Tamura, K. Fujitani, T. Tsuji, J. Matsuyama, S. Iijima, H. Imamura, K. Inoue, K. Kobayashi, Y. Kurokawa, H. Furukawa(2009).Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604). ASCO-GI2010.

前の記事 次の記事 一覧ページへ戻る